Additive Manufacturing in Medical Technology & Pharmaceutical Industry

A concept that has already existed for 80 years, has been used in various designs and industries for 40 years, and yet has only achieved a breakthrough in the last 10 years or so? Yes, you read correctly – additive manufacturing processes as one of the biggest innovation trends in the current medical technology and pharmaceutical industry has been around for quite a while. But do you know what and what potential is actually behind the term and the technologies?

Additive manufacturing or 3D printing describes the layer-by-layer production of components starting from digital 3D model data. In contrast to traditional production processes, the components are created by bonding individual layers of powder or material layer by layer. Up to now, additive manufacturing has been used increasingly for the production of prototypes or small series, but larger production runs are also possible. The biggest advantages are the use of different materials, the application of different AM technologies and the individualization of the manufactured products.

Did you know that there are already FDA-approved drugs that can be manufactured additively? Do you know the emerging trends that are being vocalized in the context of additive manufacturing in the medical technology and/or pharmaceutical industry? In the new arcoro INNOVATIONS, between informative and visionary expert interviews, also learn more about the opportunities and challenges, as well as current trends and market insights.

Facts at a glance

The first 3D printer came onto the market in 1987 and made it possible for the first time to produce complex components layer by layer and significantly faster than with conventional processes. Since the turn of the millennium, the technology has been attracting increasing interest, not least due to advances in the field of biotechnology. In general, market research institutes estimate that the global market value of 3D printing across all industries is expected to rise to 43.5 billion euros by 2030 – with particularly high growth potential seen in aerospace and medical technology. Another study predicts that the global market for 3D-printed medical devices is already expected to rise to $4.9 billion by 2026, representing a growth rate of an impressive 24.5 percent.

Your contact person

Anne Plonz

Business Analyst

Phone: +4915156319362

Email: plonz@arcoro.de

Download Innovation (PDF)

Field of expertise

Your request to us

We connect people with opportunities and knowledge

We are here for you! Whether project inquiries, market information or the desire for an active cooperation. We have a sympathetic ear for your concerns and are sure we can help quickly.